Tests comparing the distributions of conventional prognostic factors, such as age at diagnosis, DNA ploidy, INSS clinical stage, and grade of neuroblastic differentiation, showed no significant difference between MYCN amplified and non-MYCN amplified groups of High-MKI neuroblastomas. Here, MYCN is linked to neuroblastoma.